Cellectar BiosciencesCLRB
13F holders, Q2 2025 (June 30)19holders
$7.10avg. 13F price*
At the end of Q2 2025, 19 institutions reported holding Cellectar Biosciences Inc. (CLRB) in their 13F filings. The largest holders were Vanguard Group Inc. ($401K), Geode Capital Management, LLC ($103K) and HRT Financial LP ($89K).
- Company
- Cellectar Biosciences Inc.
- CUSIP
- 15117F880
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $734K |
| Exits | 0 | $0 |
Ownership 19 holders
| Vanguard Group Inc. | 0.00% | New | 56,341 | $401K |
| Geode Capital Management, LLC | 0.00% | New | 14,439 | $103K |
| HRT Financial LP | 0.00% | New | 12,578 | $89K |
| Riverview Capital Advisers, LLC | 0.02% | New | 10,500 | $75K |
| BlackRock, Inc. | 0.00% | New | 4,742 | $34K |
| UBS Group AG | 0.00% | New | 3,620 | $26K |
| Morgan Stanley | 0.00% | New | 510 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 195 | $1K |
| Simplex Trading, LLC | 0.00% | New | 238 | $1K |
| Raymond James Financial Inc. | 0.00% | New | 133 | $946 |
| Group One Trading LLC | 0.00% | New | 56 | $398 |
| Osaic Holdings, Inc. | 0.00% | New | 22 | $155 |
| SBI Securities Co., Ltd. | 0.00% | New | 11 | $78 |
| Jones Financial Companies LLLP | 0.00% | New | 3 | $24 |
| US Bancorp \de | 0.00% | New | 3 | $21 |
| Bank of America Corp. | 0.00% | New | 2 | $14 |
| Danske Bank A/S | 0.00% | New | 2 | $14 |
| Harbour Investments, Inc. | 0.00% | New | 1 | $7 |
| Citigroup Inc. | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is CLRB's weight in each manager's 13F, not the share of Cellectar Biosciences Inc. the manager owns.